An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations

Delafontaine, B;De Backer, C;Beuselinck, B;Debruyne, P;D'Hondt, Lionel;et.al.
(2020) Belgian Journal of Medical Oncology — Vol. 14, n° 2, p. 56-70 (2020)

Files

DelafontaineBDHondtL-BJMO-2020.pdf
  • Open Access
  • Adobe PDF
  • 4.51 MB
Download

Details

Authors
  • Delafontaine, BUniversity Hospital of Ghent
    Author
  • De Backer, CAZ Turnhout
    Author
  • Beuselinck, BUniversity Hospital Leuven
    Author
  • Debruyne, PAZ Groeninge
    Author
  • D'Hondt, LionelUCLouvain
    Author
  • et. al.
Abstract
The management of recurrent or metastatic renal cell carcinoma is evolving fast, with new therapeutic options becoming available that may improve the outcome of patients. In this paper, recent evolutions are discussed and recommendations are made regarding the management of renal cell carcinoma in a Belgian context.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Delafontaine, B., De Backer, C., Beuselinck, B., Debruyne, P., D’Hondt, L., & et al. (2020). An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations. Belgian Journal of Medical Oncology, 14(2), 56-70. https://hdl.handle.net/2078.5/98402 (Original work published 2020)